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Abstract: Mancozeb is a widely used fungicide approved for use in agriculture in many countries
with long persistence in the environment and consequent bioaccumulation in tissues and biological
fluids. Despite the large amount of studies published in recent years, the relationship between
mancozeb exposure and female reproductive health is not fully elucidated. In order to summarize
current evidence on mancozeb exposure and female reproductive disease, we performed a systematic
review of literature. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
guidelines were used to make this review. An adapted version of the National Toxicology Program’s
Office of Health and Assessment and Translation (OHAT) framework was used to evaluate the risk of
bias. Electronic search on two databases (PubMed and Scopus) was used to find experimental studies
(in vitro and in vivo) on mancozeb exposure. The database search identified 250 scientific articles,
20 of which met our inclusion criteria. Selected data were then reviewed and summarized in tables.
Overall, mancozeb represents a hazard for female reproductive health, with different mechanisms
of action. Undoubtedly more experimental and epidemiological studies are required to definitively
validate mancozeb as reproductive toxicant.
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1. Introduction
Nowadays female subfertility is a widespread health concern [1–6]. In fact, up to one in six couples
in Western countries is affected by infertility [7]. The most important risk factors in the development of
female subfertility include: the age of the woman [6], ovulatory disorders, chromosomal abnormalities,
and defective male fertility [8–10]. A widespread variety of environmental pollutants, such as several
classes of pesticides, heavy metals, and air particulate matter plays a key role in the pathogenesis of
female infertility [8,11,12].
Indeed, female fertility and reproductive health are sensitive to toxic exposure, specifically to
endocrine disruptor pollutants [13], and have long-term adverse effects. However, several studies have
analyzed the connection between environmental air pollution and female reproductive competence,
suggesting an adverse linkage between fertility and toxicants [14].
Among environmental pollutants an important role is played by persistent organic pollutants
(POPs), whose application can cause adverse health effects in animal models and humans [15–17].
Different types of POPs are widely used in agriculture, and present a very strong persistence, especially
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on leaves, with bioaccumulation in the food web [15,16]. Pesticides act as endocrine disruptor chemicals,
possibly leading to low fecundability, miscarriage, preeclampsia, polycystic ovary syndrome (PCOS),
endometriosis, and alterations in the menstrual cycle [15,16,18]. Thus, pesticides may negatively affect
female reproductive competence both in adulthood and during embryonic development [19,20].
One of the most important endocrine disruptors, with a wide range of agricultural and industrial
applications, is mancozeb. Mancozeb (ethylene bis-dithiocarbamate fungicide (EBCD)) was first
registered in the United States in 1948 [21] and introduced in the global fungicide market in 1962 [22].
Mancozeb fungicidal efficacy has been applied in different agricultural and industrial contexts, for
example in major agricultural crops (tomato, potato, grapevine), and its use will likely increase by
the 2020s due to its low price, global demand for fruits and vegetables, and non-selective fungicidal
efficacy [21]. In this context, the main source of exposure to mancozeb is the assumption of contaminated
products (e.g., tomatoes, potatoes, citrus fruits) or drinking water [21], while occupational exposure
includes inhalation, accidental ingestion, and dermal contact of the fungicide, among industrial and
agricultural workers [21].
Mancozeb exposure induces a wide range of environmental hazard, such as Parkinson-like
symptoms, thyroid hormone dysfunctions, and defects in fetal development [21,23]. As confirmed
by recent studies, mancozeb exposure is a risk factor for spontaneous abortion, maternal mortality,
and fetal malformations in rat and rabbit experimental models [21]. Moreover, it is strongly linked
to teratogenic, mutagenic, and carcinogenic risks [24] because of its ability to induce genotoxic and
malignant alterations in human ovarian cells [21,25,26].
For these reasons, we performed a review of scientific literature to summarize current evidence
of the influence of mancozeb on female reproductive health. This systematic approach is useful to
understand mancozeb’s mechanism of action and role for reproductive and overall female health.
2. Materials and Methods
2.1. Search Strategy
This systematic review screened PubMed (www.ncbi.nlm.nih.gov) and Scopus (https://www.
scopus.com/standard/marketing.uri) databases to select high-profile studies. Studies dealing with
in vitro models were screened from January 2002 to December 2019. Studies dealing with mammalian
models were screened from January 1973 to December 2019.
2.2. Search Terms
A wide range of keywords were used: “Mancozeb” or “ethylene thiourea (ETU)” or
“dithiocarbamates” and (1) “reproductive effect” or “infertility” or “reproductive toxicity”; (2) “birth
outcomes” or “pregnancy” or “chronic exposure”. This electronic search combined terms and
descriptions linked to mancozeb exposure and female reproductive health. We also screened the
related references of all relevant articles and overviews.
2.3. Inclusion and Exclusion Criteria
We included in vitro studies, with increasing concentrations of mancozeb added in cell culture
and in vivo studies with oral or injected mancozeb administration, to assess the effect of mancozeb
on female reproductive competence. The exclusion criteria of this systematic review were: (1) no
peer-review (e.g., review articles and editorials excluded); (2) lack of reproductive and health outcomes;
(3) lack of data on mancozeb exposure; (4) human study population; (5) male study population;
and (6) non-English articles. The included articles evaluated the association between mancozeb
(or agrochemicals mixtures) exposure and reproductive female health.
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2.4. Study Selection
Two independent authors (S.B. and S.A.N.) dealt with the primary literature research. The same
researchers conducted a second re-evaluation of the selected titles in which the studies not adapting to
the established eligibility and inclusion criteria were deleted. Therefore, the remaining reports were
deeply screened considering the full-text articles for compatibility. In case of any disagreement between
the authors after independent evaluation, consensus was reached by re-evaluation and discussion.
In the event of discrepancies in the data, when possible, reference paper authors were contacted
by email for further explanation. The remaining studies were finally reviewed for qualitative synthesis.
We adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
guidelines [27].
2.5. Data and Quality of Data Evaluation Strategy
We adhered to the National Toxicology Program’s Office for Health Assessment and Translation
(OHAT) systematic review framework [28] to evaluate mancozeb reproductive toxicity. The internal
validity of the included studies was assessed by the OHAT Risk of Bias Rating Tool [29,30]. Confidence
ratings were evaluated for each included study considering the study design (Table 1).
Table 1. Confidence ratings for mancozeb health effects.
Level of Confidence for Health Effects
++++ High Confidence Association between substance exposure and the outcome. The trueeffect is highly likely to be reflected in the apparent relationship.
+++ Moderate Confidence Association between substance exposure and the outcome. The trueeffect may be reflected in the apparent relationship.
++ Low Confidence Association between substance exposure and the outcome. The trueeffect may be different from the apparent relationship.
+ Very Low Confidence Association between substance exposure and the outcome. The trueeffect is highly likely to be different from the apparent relationship.
3. Results
After literature screening, a total of twenty studies were found eligible for the qualitative synthesis.
Among them, seven in vitro studies were found eligible and thirteen studies using mammalian models
were found meeting our inclusion criteria (Figure 1).
3.1. In Vitro Experimental Studies
Seven in vitro studies, published between 2002 and 2018, met our inclusion criteria and examined
mancozeb toxicological and reproductive effects on female subjects. Six studies used mammalian cells
in the study design, and all the included in vitro studies demonstrated mancozeb’s power to disrupt
female reproduction from a cellular to a molecular and toxicological point of view (Table 2).
Fejes et al. suggested the absence of toxic effects on chicken embryos after 19 days of mancozeb
administration (dithane M-45, 80% mancozeb). Instead, an increased mortality on chicken embryos
was registered from combined exposure to mancozeb and copper-sulfate (0.1% concentration), when
compared to individual doses [31]. Greenlee et al. found a decrease in mouse blastocyst development
after low-dose exposure to mancozeb (0.003 µg/mL), with increased apoptosis during blastocyst
formation [32].
Mancozeb (1.0, 2.5, and 5.0 µg/mL) also affects cytoplasmic and nuclear maturation during in vitro
maturation in buffalo oocytes, inducing a dose-dependent oocyte degeneration [33]. Abdoon et al. also
reported the presence of fragmented zona pellucida and cytoplasm in buffalo oocytes [33]. Instead,
during in vitro fertilization, a reduction in embryo development (to morula and blastocyst stage)
occurred, with cytoplasm degeneration, in all the exposed embryos [33].
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Paro et al. showed how increasing concentrations of mancozeb (0.001–1 µg/mL) induce alterations
in morphology and migration patterns in mouse granulosa cells, with a reduction in p53 expression
levels [25]. Human granulosa cells, derived from women who underwent assisted reproductive
therapy, when exposed to increasing mancozeb concentrations, showed alteration in p53 levels and
morphology changes. Reduced expression of p53, due to mancozeb administration (0.01 µg/mL), was
also confirmed by Iorio et al. in mouse granulosa cells [34] during 36 h of incubation. They also found a
depolarization in mitochondrial membrane and a reduction in ATP levels. At the same time, a decrease
in glutathione (GSH) levels occurred with an increase in reactive oxygen species (ROS) production [34].
Dose-dependent mancozeb toxicity on reproductive female health was also confirmed by Palmerini et al.
who showed mancozeb’s potential to induce ultrastructural and cellular alterations in mouse granulosa
cells exposed to increasing concentrations of this fungicide (0.001, 0.01, and 1 µg/mL) [22]. They also
highlighted the association between mancozeb administration intercellular contact alteration and
chromatin marginalization, phenomena strongly linked with apoptosis and cellular degeneration [22].
Finally, Atmaca et al. demonstrated how mancozeb exposure (1 µM) determines a significant
decline in steroids synthesis (day 3 and 5) in bovine luteal cells, when compared to controls [35].
Int. J. Environ. Res. Public Health 2020, 17, x 4 of 17 
 
 
Figure 1. Flow chart of the experimental study selection process. 
3.1. In Vitro Experimental Studies 
Seven in vitro studies, published between 2002 and 2018, met our inclusion criteria and 
examined mancozeb toxicological and reproductive effects on female subjects. Six studies used 
mammalian cells in the study design, and all the included in vitro studies demonstrated mancozeb’s 
power to disrupt female reproduction from a cellular to a molecular and toxicological point of view 
(Table 2). 
Fejes et al. suggested the absence of toxic effects on chicken embryos after 19 days of mancozeb 
administration (dithane M-45, 80% mancozeb). Instead, an increased mortality on chicken embryos 
was registered from combined exposure to mancozeb and copper-sulfate (0.1% concentration), when 
compared to individual doses [31]. Greenlee et al. found a decrease in mouse blastocyst development 
after low-dose exposure to mancozeb (0.003 µg/mL), with increased apoptosis during blastocyst 
formation [32]. 
Mancozeb (1.0, 2.5, and 5.0 µg/mL) also affects cytoplasmic and nuclear maturation during in 
vitro maturation in buffalo oocytes, inducing a dose-dependent oocyte degeneration [33]. Abdoon et 
al. also reported the presence of fragmented zona pellucida and cytoplasm in buffalo oocytes [33]. 
Instead, during in vitro fertilization, a reduction in embryo development (to morula and blastocyst 
stage) occurred, with cytoplasm degeneration, in all the exposed embryos [33]. 
Paro et al. showed how increasing concentrations of mancozeb (0.001–1 µg/mL) induce 
alterations in morphology and migration patterns in mouse granulosa cells, with a reduction in p53 
expression levels [25]. Human granulosa cells, derived from women who underwent assisted 
reproductive therapy, when exposed to increasing mancozeb concentrations, showed alteration in 
p53 levels and morphology changes. Reduced expression of p53, due to mancozeb administration 
(0.01 µg/mL), was also confirmed by Iorio et al. in mouse granulosa cells [34] during 36 h of 
incubation. They also found a depolarization in mitochondrial membrane and a reduction in ATP 
levels. At the same time, a decrease in glutathione (GSH) levels occurred with an increase in reactive 
Figure 1. Flow chart of the experimental study selection process.
Int. J. Environ. Res. Public Health 2020, 17, 2580 5 of 15
Table 2. In vitro studies: mancozeb exposure and reproductive outcomes. Confidence ratings in the body of evidence ratings: High Confidence (++++) in the
association between mancozeb exposure and female reproductive outcomes. The true effect is highly likely to be reflected in the apparent relationship. Moderate
Confidence (+++) in the association between mancozeb exposure and female reproductive outcomes. The true effect may be reflected in the apparent relationship.
Low Confidence (++) in the association between mancozeb exposure and female reproductive outcomes. The true effect may be different from the apparent relationship.
Very Low Confidence (+) in the association between mancozeb exposure and female reproductive outcomes. The true effect is highly likely to be different from the
apparent relationship.
Author
(Year) Type of Cell/Tissue
Compound
(Daily Dose) Incubation Outcomes Confidence
Fejes et al. (2002) 288chicken embryos
80% mancozeb
containing formulation
(dithane M-45)
19 days No toxic effect on embryos.Increased mortality in embryos in combination mixtures. ++
Greenlee et al.
(2004) Mice embryos
Low-doses of
agrochemicals
mancozeb (0.003 µg/mL)
96 h Reduced development of mouse blastocysts.Increased apoptosis during blastocyst formation +++
Abdoon et al.
(2011) Buffalo oocytes
Mancozeb
(1.0, 2.5, and 5.0 µg/mL) 24 h
In vitro maturation:
mancozeb affects cytoplasmic and nuclear maturation.
Dose-dependent oocyte degeneration.
Fragmented cytoplasm and broken zona pellucida.
In vitro fertilization:
lower embryo development to morula and blastocyst stage.
Fragmented and degenerated cytoplasm in all the
exposed embryos.
+++
Paro et al.
(2012) Mouse granulosa cells
Increasing concentrations
of mancozeb
(0.001–1 µg/mL)
1, 24, and 36 h
Mouse:
morphology changes;
migration pattern;
p53 reduced expression;
no changes in apoptosis.
Human:
morphology changes;
p53 reduced expression.
++++
Iorio et al.
(2015) Mouse granulosa cells
Mancozeb
(0.01 µg/mL) 36 h
p53 reduced expression.
Depolarized mitochondrial membrane potential.
Decreased ATP levels.
Decreased glutathione levels (GSH).
Increased reactive oxygen species (ROS).
++++
Palmerini et al.
(2018) Mouse granulosa cells
Increasing concentrations
of mancozeb (0.001, 0.01,
0.1, and 1 µg/mL)
36 h Dose-dependent toxicity of mancozeb on mouse granulosa cells. ++++
Atmaca et al.
(2018) Bovine luteal cells
Mancozeb
(0.01, 0.1, and 1 µM) 4 days
Mancozeb exposure (1 µM) induces a significant decline (day 3
and 5) in steroidogenesis, compared to controls. +++
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3.2. In Vivo Experimental Studies
Thirteen studies with various experimental models (rats, mice, and rabbits), published between
1973 and 2019, adhered to our inclusion criteria. In these experimental studies, mancozeb was
administered orally, via gavage, in drinking water and mixed into the diet. Two studies assessed
mancozeb exposure, when mixed with other agrochemicals compounds (Table 3).
To this aim, Khera et al. showed that oral ETU administration (0.5, 10, 20, 40, or 80 mg/kg/day),
on adult female Wistar rats and New Zealand White rabbits had no significant effects before and during
pregnancy [36]. In fact, no maternal toxicity or fetal death in offspring was reported. In addition,
Castro et al. confirmed the absence of menstrual cycle alteration in Wister rats exposed to mancozeb
concentrations. At the same time, mancozeb do not influence the number of live pup births [37].
Studies conducted on female virgin Wistar rats demonstrated that oral mancozeb administration
(500, 600, 700, and 800 mg/kg/day) induces a reduction in ovary enlargement (highest doses:
700–800 mg/kg/day) and does not affect the estrous cycle (500 mg/kg/day). In this context,
Mahadevaswami et al. found a huge decline in follicles counts and an increase in defective ovarian
follicles (800 mg/kg/day) [38]. Baligar and Kaliwal, instead, found that mancozeb oral exposure (500,
600, 700, and 800 mg/kg/day), in the same experimental model, induces a progressive decline in
the number of healthy follicles and significant changes in the estrous cycle (proestrus, estrous, and
metestrus phases) [39]. These data are confirmed by the same author in a 2004 study, where mancozeb
exposure (700 mg/kg/day) in female virgin albino rats was associated to the progressive decline of
healthy follicles, more atretic follicles, and alteration in the estrous cycle [40].
Higher exposure of mancozeb (500 mg/kg) in the prenatal period is linked to oocytes degeneration
and a decrease in fertilization competence [41]. Hass et al., instead, suggested that mancozeb exposure
(highest concentration: 25 mg/kg/day) induces a longer gestation period in female Wistar rats [42].
Other studies demonstrated that mancozeb administration (via gavage; mixture composition, 6.25,
12.5, 18.75, 25.0, and 31.25 mg/kg/day) does not determine changes in uterus and ovary weight [43],
even if there are more perinatal deaths and impaired parturition [44].
Oral mancozeb exposure (800 mg/kg/day) also reduces litter size and weight with a relevant
decrease in ovary weight [45]. In this context, there was also an increase in atretic follicles and a
reduction in healthy oocytes. Liu et al. also reported ultrastructural changes in Germinal Vesicle (GV)
oocytes due to mancozeb administration [45]. Noteworthy, is the decrease in the number of pronuclei
and two-cells of parthenogenetic activated oocytes and the alteration in actin expression levels [45].
There is an increase in apoptotic pathways and ROS production, with an abnormal mitochondrial
distribution. Finally, mancozeb exposure is strongly linked to epigenetic modifications, which can
compromise female fecundability [45]. Other studies suggest the potential of ethylene thiourea to
influence important biomarkers of ovarian aging, in CD-1 mice exposed to 0.1, 1, and 10 mg/kg/day,
from conception to postnatal day 21 [46].
Among our most recent data, Mahdi et al. showed that gavage mancozeb administration
(500 mg/kg), in first generation mouse female pups, induces depletion of germ cells in female gonads
with the presence of more atretic follicles [47]. Esmaiel et al. reported a decrease in the number of
collected oocytes and a defective maturation, fertilization, and implantation process after mancozeb
treatment (gavage; 500 vmg/kg) [48]. Esmaiel et al. also found defective embryo development in their
experimental model as well as a compromised fecundity rate.
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Table 3. In vivo studies: mancozeb exposure and reproductive outcomes. Confidence ratings in the body of evidence ratings: High Confidence (++++) in the
association between mancozeb exposure and female reproductive outcomes. The true effect is highly likely to be reflected in the apparent relationship. Moderate
Confidence (+++) in the association between mancozeb exposure and female reproductive outcomes. The true effect may be reflected in the apparent relationship.
Low Confidence (++) in the association between mancozeb exposure and female reproductive outcomes. The true effect may be different from the apparent relationship.
Very Low Confidence (+) in the association between mancozeb exposure and female reproductive outcomes. The true effect is highly likely to be different from the
apparent relationship.
Author
(Year)
Experimental
Animal n
Compound
(Route) Daily Dose Duration Outcomes Ratings
Khera et al. (1973)
Adult nulliparous
female Wistar rats,
New Zealand
White rabbits
209 rats,
33 rabbits
Ethylene thiourea
(ETU; oral)
0, 5, 10, 20, 40, or
80 mg/kg/day
Rats
Group 1:
21–42 (before gestation),
1–15 days (gestation)
Group 2:
6–15 (gestation)
Group 3:
7–20 days (gestation)
Rabbits: 30 days (gestation)
No changes in the number of
viable fetuses or in fetal death.
80 mg/kg of ETU have no
significant effect before and
during pregnancy.
++++
Castro et al. (1999) Wister rats 120 Mancozeb(mixed in diet) 0, 2000–3000 ppm
Group A:
1–6
(gestation days)
Group B:
6–15
(gestation days)
No changes in estrous cycle
during pregnancy.
No changes in the number of
live pup births.
+++
Mahadevaswami et al.
(2000)
Female Wistar
virgin rats 36
Mancozeb
(oral)
500, 600, 700, and
800 mg/kg/day
15
(before gestation days)
Decrease in ovary
enlargement (700 and
800 mg/kg/day).
No changes in estrous cycle
(500 mg/kg/day).
Decline in health follicle
counts and a defective
ovarian follicle rise
(800 mg/kg/day).
++++
Baligar et Kaliwal
(2001) Wister virgin rats 40
Mancozeb
(oral)
500, 600, 700, and
800 mg/kg/day 30 days
Decline in number of estrous
cycle and healthy follicles,
with changes in proestrus,
estrus. and metestrus phases.
+++
Baligar et Kaliwal
(2004)
Female virgin
albino rats 70
Mancozeb
(75% wettable
powder,
olive oil; oral)
700 mg/kg/day 5, 10, 20, or 30 days (before gestation)
Alteration in diestrus and
estrous cycle.
Decline of healthy follicle
numbers.
Atretic follicles increase.
+++
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Table 3. Cont.
Author
(Year)
Experimental
Animal n
Compound
(Route) Daily Dose Duration Outcomes Ratings
Rossi et al.
(2006)
Swiss CD-1 female
mice 25
Mancozeb
(sesame oil; oral) 50 and 500 mg/kg Gestation day 2, pup day 20
Eggs decline (ovulation) and
fertilizability decreases. +++
Hass et al.
(2012)
Nulliparous
time-mated young
adult female
Wistar rats
198
Mancozeb
(mixture
composition;
gavage)
6.25 and
25 mg/kg/day
7–21
(gestation day)
1–16
(pup day)
Longer gestation period
(highest concentration). ++++
Jacobsen et al.
(2012)
Nulliparous
time-mated young
adult female
Wistar rats
198
Mancozeb
(mixture
composition;
gavage)
6.25 and
25 mg/kg/day Gestation day 7, pup day 16
No reproductive organ
weight alterations
(uterus and ovary).
++++
Jacobsen et al.
(2010)
Nulliparous
time-mated young
adult female
Wistar rats
80
Mancozeb
(mixture
composition;
gavage)
6.25, 12.5, 18.75,
25.0, and
31.25 mg/kg/day
Gestation day 7–day before expected birth
(GD21)
Higher perinatal pup
mortality and impaired
parturition.
++++
Liu et al.
(2017)
CD-1 mice
(4–6 weeks old) 240
Mancozeb
(oral) 800 mg/kg/day 4 weeks
Mancozeb reduces litter size
and weight.
Decreased ovary weight.
Increased atretic follicles and
decreased normal oocytes.
Ultrastructural alterations in
GV oocytes.
Decrease in the number of
pronuclei and two-cells of
parthenogenetic
activated oocytes.
Changes in actin
expression levels.
Increase in apoptosis and in
ROS production.
Abnormal mitochondrial
distribution and
mitochondrial
membrane alterations.
Epigenetic modifications.
++++
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Table 3. Cont.
Author
(Year)
Experimental
Animal n
Compound
(Route) Daily Dose Duration Outcomes Ratings
Cuomo et al.
(2018) CD-1 mice 20
Ethylene thiourea
(ETU; drinking water)
0.1, 1, and
10 mg/kg/day
From conception (through mothers) to
postnatal 21 days.
ETU influences ovarian aging
biomarkers at all doses. ++++
Mahdi et al.
(2019)
First-generation
(F1) mouse female
pups
36 Mancozeb(oral gavage) 500 mg/kg From day 2 of pregnancy to postnatal 20 days.
Apoptotic follicles.
Remarkable germ cells
depletion in gonads.
++++
Esmaiel et al.
(2019)
First-generation
(F1)
female pups
60 Mancozeb(oral gavage)
500 mg/kg (olive
oil; mothers) From day 2 of pregnancy to postnatal 21 days.
Reduction of number of
collected oocyte.
Comprised oocyte maturation,
fertilization, implantation,
and fecundity rate.
Comprised embryo
development.
++++
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4. Discussion
The studies included in this systematic review, published between 1973 and 2019, confirm that
lower and higher mancozeb concentrations, individually or administered in combination with other
agrochemical compounds, compromise female reproductive health.
High and moderate levels of confidence, as regards in vitro studies, prove the ability of mancozeb
to affect, directly or indirectly, female reproductive competence, by exerting its toxicity in the cellular
environment from an ultrastructural to a molecular point of view.
To this aim, Abdoon et al. suggested that mancozeb induces a dose-dependent degeneration
process in buffalo oocytes during in vitro maturation [33]. Mancozeb exposure indeed affects
cytoplasmic and nuclear maturation: this fungicide reduces the oocyte nuclear maturation, with a
direct effect on female reproductive cells [33]. At the same time, mancozeb exposure influences embryo
development, especially in the morula and blastocyst stages. In this context, embryos exposed to
different concentrations of mancozeb show fragmented and degenerated cytoplasm [33]. In addition,
Greenlee et al. reported a significant decrease in mouse blastocyst development [32]; conversely,
Fejes et al. found that mancozeb has no toxic effects on embryo and blastocyst development [31].
As regards mancozeb’s molecular effects in a reproductive context, increasing concentrations of
this fungicide (0.001–1 µg/mL) induce a significant reduction in p53 expression levels, as suggested
by Paro et al. in mouse granulosa cells [25]. This data are also confirmed by Iorio et al., whose study
confirms the bidirectional linkage between p53 downregulation and higher ROS production, due to
fungicide exposure [34]. Paro et al. also registered important alterations on granulosa cells morphology
with reorganization of the actin cytoskeleton and acquisition of migratory competence, both in mouse
then in human models [25]. Moreover, Iorio et al. highlighted a significant linkage between mancozeb
exposure and mitochondrial membrane depolarization, leading to mitochondrial dysfunctions [34].
They also found that mancozeb-induced oxidative stress affects glutathione homeostasis, promoting a
parallel ATP depletion [34]. In this context, ROS bioaccumulation, changes in GSH and ATP levels,
p53 reduced expression, and mitochondrial potential perturbation increase the likelihood for DNA
damage and apoptotic mechanisms in reproductive cells, as confirmed by different studies [49].
An ultrastructural overview about mancozeb’s reproductive effects on mouse granulosa cells
was provided by Palmerini et al., who found nuclear membrane irregularities, intercellular contact
alterations, cytoplasmic vacuolization, and chromatin condensation in mouse granulosa cells exposed
to the highest levels of mancozeb [22] (Figure 2). This study confirms mancozeb gonadal toxicity,
highlighting the fungicide’s power to disrupt female reproductive competence from an ultrastructural
point of view.
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Intermediate stage: nuclear collapse, with the formation of apoptotic bodies and loss of plasma 
membrane integrity (*); 3) Late stage: apoptotic bodies and cell debris associated to secondary 
necrosis. TEM scale bar: 2 mm. 
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fertilization [48]; in this context, lower-quality oocytes are associated with lower fertilization rates 
and depleted embryonic implantation. In addition, for Liu et al., oocyte quality is damaged by 
mancozeb exposure; in fact, ultrastructural alterations in GV oocytes were reported, such as changes 
in actin expression levels, with decreased development potential of these oocytes [45]. 
Finally, two studies shed light on mancozeb’s potential to influence female reproductive 
competence, from a genetic to an epigenetic point of view. To this aim, Cuomo et al. suggested that 
ethylene thiourea exposure in mouse models leads to a remarkable dysregulation of ovarian aging 
biomarkers, affecting ovarian health [46]. Environmental exposure to ETU, in fact, induces alterations 
in the estrous cycle, considered the beginning of an early reproductive senescence [37,39,40,46,50]. 
Figure 2. Representative transmission electron microscopy micrograph of mancozeb subcellular
damage on ovarian mouse granulosa cells. Different stages of apoptotic cell death induced in vitro
(0.01 mg/mL) are detectable: (1) Early stage: cell shrinkage, formation of blebs (b), dilatation and
indentation of nuclear membrane (nm), heterochromatin (He) marginalization, vacuolization (V);
(2) Intermediate stage: nuclear collapse, with the formation of apoptotic bodies and loss of plasma
membrane integrity (*); (3) Late stage: apoptotic bodies and cell debris associated to secondary necrosis.
TEM scale bar: 2 mm.
In addition, t aca et al. found that ancozeb induces a progressive decline in steroid synthesis
in bovine luteal cells [35]. In this study, mancozeb showed unfavorable effects on luteal cells, considered
functional structures in the ovary, for their role in steroidogenesis.
s regards in vivo experi ental studies, higher and oderate levels of confidence suggest that
lo an high oses of ancozeb or ecrease ovary eight [45] an enlarge ent [38]. n the
contrary, Jacobsen et al. found no reproductive organ eight changes, especially in the uterus and
ovary, in rat odels exposed to ancozeb [43].
ualitative and quantitative follicles’ alterations are also associated to ancozeb exposure:
ahadevas a i et al. found a progressive decline in health follicle counts, ith a defective ovarian
follicle rise, in rat models [38]. These data are also confirmed by Baligar et al. who highlight the
same decline in a similar experimental model [39,40]. Liu et al. reported a significant increase in
atretic follicles, in parallel with a decrease in the number of healthy follicles, in mouse models [45].
oreover, ahdi et al. found a re arkable nu ber of apoptotic follicles in ancozeb-treated ouse
pups, probably due to the increased R S production in the cellular environ ent [47].
s regards oocyte quality, Rossi et al. found that ancozeb exposure in ouse odels i pairs
oocyte co petence by inducing a progressive egg decline, especially during ovulation [41]. Esmaiel et al.,
instead, suggested that mancozeb exposure has a detrimental effect on oocyte aturation and
fertilization [48]; in this context, lower-quality oocytes are associated with lower fertilization rates and
depleted embryonic implantation. In addition, for Liu et al., oocyte quality is damaged by ancozeb
exposure; in fact, ultrastructural alterations in GV oocytes were reported, such as changes in actin
expression levels, with decreased development potential of these oocytes [45].
Finally, t o studies shed light on ancozeb’s potential to influence fe ale reproductive
co petence, fro a genetic to an epigenetic point of view. To this aim, Cuomo et al. suggested
that ethylene thiourea exposure in mouse models leads to a remarkable dysregulation of ovarian aging
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biomarkers, affecting ovarian health [46]. Environmental exposure to ETU, in fact, induces alterations in the
estrous cycle, considered the beginning of an early reproductive senescence [37,39,40,46,50]. Furthermore,
Liu et al. suggested that specific histone modifications may influence the full developmental competence
of mouse oocytes when exposed to mancozeb. These epigenetic modifications (e.g., H3K4me and
H3K27me2), in fact, impair oocyte maturation process, compromise embryo development, and promote
apoptotic pathways in the female reproductive environment [45].
Beyond experimental settings, mancozeb exerts a significant role on human public health.
For 70 years, mancozeb has been applied in different agricultural contexts [21], specifically on major
crops (tomato, potato, grapevine). It is likely that the increasing global demand for fruits and vegetables
(also due to new eating habits, such as vegetarian and vegan diet) will boost mancozeb production in
the next years, with different human side effects. A sensitive segment of the population, exposed to
mancozeb, is represented by pregnant women, who use agricultural products and are at risk from
their side effects. In this context, mancozeb crosses the blood–placenta [48,51,52] and the blood–milk
barriers [53], compromising the development of offspring, from intrauterine to postnatal life [54].
The U.S. Environmental Protection Agency (EPA) evaluated the dietary risk of mancozeb from
residues in foods, establishing the value of the population adjusted dose (PAD). The latter may be
considered the reference dose for acute and chronic exposure (aPAD and cPAD). The chronic dietary
risk from food was assessed by using the average consumption data for vegetables and average residue
values on those foods. The number of residues varies on different fruits and vegetables, depending on
the specific features of the foods. The EPA reported a cPAD value of 0.16 mg/kg/day. This is the dose at
which the general population could be exposed over the course of a lifetime with no expected adverse
health effects [24].
However, it must be considered that the EPA recognized a weakness of data regarding the link
between mancozeb intake and reproductive impairment. To this intent, the Agency established a
reduction of the cPAD by a factor of 10 (the so-called safety factor) to ensure adequate protection
to women of reproductive age and for children less than six years old, setting the cPAD to
0.016 mg/kg/day [24,55].
5. Conclusions
As proved by this systematic review, mancozeb can be considered as a powerful threat for female
reproductive competence and in vitro/in vivo models are useful to evaluate reproductive hazards.
Due to its persistence and versatile profile, this fungicide compromises female reproduction in different
ways. In this context, mancozeb is an epigenetic hazard and a powerful environmental pollutant, which
interacts with female reproductive phenotypes, changing directly or indirectly the inner molecular and
cellular balances.
For this reason, even if the available evidence gives more insight on mancozeb gonadal toxicity,
further studies are required for a complete etiologic and epidemiologic understanding of this health
concern. However, this review may contribute to fulfil the gap in risk assessment of mancozeb
reproductive impairment and may also be useful for government agencies in normative decision-making
on environmental and occupational health.
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